by Margaret | 1 May 2020 | Clinical Trials
The Gorlin Syndrome Group has today received a communication from PellePharm regards the status of this global trial. PellePharm want to sincerely thank you for your dedicated partnership and for the community’s ongoing support of our clinical program aimed at...
by Margaret | 30 Jan 2019 | Clinical Trials
A trial to evaluate patidegib gel in preventing BCCs on the face will start soon. Participants need to have had 10 or more BCCs in the previous two years have two BCCs on the face at the time of the trialThere is a 50:50 chance of getting patidegib or a placebo....
by Margaret | 17 Oct 2018 | Clinical Trials
PellePharm presents updated data from Phase 2 Studies demonstrating the potential of Patidegib Topical Gel to treat Basal Cell Carcinomas in patients with Gorlin Syndrome and in patients with non-Gorlin sporadic BCCs. PellePharm, a late clinical-stage...
by Margaret | 5 May 2018 | Clinical Trials
This Phase 3 trial is being conducted by PellePharrm, Inc., a biotech company located in the United States. The trial is for Patidegib Gel a topical treatment for the treatment of basal cell carcinomas. Increasingly the patient voice has become recognised as a...
by Margaret | 4 Dec 2017 | Clinical Trials
Early in 2016 a study commenced in the UK at Manchester Royal Infirmary and The Royal London Hospital. The study involved testing a new medication called Patidegib Gel in individuals who have Gorlin Syndrome aged 18 – 25 years, also known as nevoid basal cell...
by Margaret | 5 Feb 2016 | Clinical Trials
Thinking about participating in a clinical trials? In recent years many individuals with Gorlin Syndrome have participated in trials on offer in the UK. Before reaching a decision whether to take part many people have doubts and questions regarding the benefits and...
